Sign inJoin waitlistJoin the waitlist

Sandra Hurtado

Assistant Professor, Principal Investigator · University of Texas Health Science Center at Houston

Credentials: · · ·

History

University of Texas Health Science Center at Houston
Present

Obstetrics and Gynecology
University of Chicago Medical Center
1990–1994
The Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania
1986–1990

Research

Elagolix for Heavy Menstrual Bleeding in Women with Uterine Fibroids
New England Journal of Medicine · 2020 · 145 citations
Substance P: the relationship between receptor distribution in rat lung and the capacity of substance P to stimulate vascular permeability
American Review of Respiratory Disease · 1988 · 70 citations
Elagolix Treatment for Up to 12 Months in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas
Obstetrics and Gynecology · 2020 · 51 citations

DA
David Archer
4 papers
Eve Feinberg
4 papers
Kurt Barnhart
4 papers
Linda Bradley
4 papers
OM
Ozgul Muneyyirci-Delale
4 papers
Ayman Al-Hendy
3 papers
BC
Bruce Carr
3 papers
ES
Elizabeth Stewart
3 papers
JS
James Simon
3 papers
Veronica Gillispie-Bell
3 papers
WS
William Schlaff
3 papers
Elizabeth Puscheck
2 papers

Clinical trials

Proof of Concept Study to Eval MetriDx Lab-developed Test to Identify Endometriosis-specific Bio Markers
Principal investigator · Recruiting · Phase 2
Hera Biotech, Inc.
2022–2023
Efficacy/Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms (VMS)
Principal investigator · Completed · Phase 3
Noven Therapeutics
2011–2012
24-Week Efficacy & Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms
Principal investigator · Completed · Phase 3
Noven Therapeutics
2010–2011